HALOPERIDOL

Details

Stereochemistry	ACHIRAL
Molecular Formula	C21H23ClFNO2
Molecular Weight	375.864
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3

InChI

InChIKey=LNEPOXFFQSENCJ-UHFFFAOYSA-N

InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

HIDE SMILES / InChI

Approval Year

Show entries

Name

Type

Language

HALOPERIDOL

Official Name

English

HALOPERIDOL COMPONENT OF VESALIUM

Brand Name

English

EUKYSTOL

Common Name

English

HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]

Common Name

English

VESALIUM COMPONENT HALOPERIDOL

Brand Name

English

Showing 1 to 5 of 36 entries

Previous1 2 3 4 5…8Next

Show entries

Classification Tree

Code System

Code

Antipsychotic

LIVERTOX

NBK548393

Established Pharmacologic Class

NDF-RT

N0000180182

Butyrophenone derivatives

WHO-ATC

N05AD01

Medicines for mental and behavioural disorders

WHO-ESSENTIAL MEDICINES LIST

24.1

Butyrophenone derivatives

WHO-VATC

QN05AD01

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

WHO INTERNATIONAL PHARMACOPEIA

HALOPERIDOL

PRIMARY

Description: A white to faintly yellowish, amorphous or microcrystalline powder; odourless. Solubility: Practically insoluble in water; soluble in 50 parts of ethanol (~750 g/l) TS and in 200 parts of ether R. Category: Neuroleptic. Storage: Haloperidol should be kept in a well-closed container, protected from light. Definition: Haloperidol contains not less than 98.0% and not more than 101.0% of C21H23ClFNO2, calculated with reference to the dried substance.

IUPHAR

86

PRIMARY

RS_ITEM_NUM

1303002

PRIMARY

CHEBI

5613

PRIMARY

DRUG BANK

DB00502

PRIMARY